Literature DB >> 3019673

Differential regulation of papilloma virus early gene expression in transformed fibroblasts and carcinoma cell lines.

E Kleiner, W Dietrich, H Pfister.   

Abstract

Treatment of bovine papilloma virus (BPV) 1-transformed mouse fibroblasts with cycloheximide led to a 10-fold increase in the amount of viral transcripts, after as little as 1 h of protein synthesis inhibition. Northern blots revealed no qualitative changes in the RNA pattern. Nuclear run-on experiments showed about a 7-fold increase in specific transcriptional activity after cycloheximide treatment. The half-life of BPV1 mRNA was twice as long as in untreated controls. These results indicate that both RNA synthesis and degradation of viral RNA are controlled by labile proteins. Cycloheximide stimulation turned out to be independent of the BPV1 E2 gene activity which enhances viral transcription. Cycloheximide treatment had no effect on the amount of human papilloma virus (HPV) 18 transcripts in cervical carcinoma derived HeLa and C4-1 cells. Transcription of HPV16 in the cervical carcinoma line SiHa was likewise unaffected. The differential regulation of transcription in transformed fibroblasts and cancer-derived cells, and the significance for malignant conversion are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019673      PMCID: PMC1167062          DOI: 10.1002/j.1460-2075.1986.tb04448.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  35 in total

1.  Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix.

Authors:  M M Pater; A Pater
Journal:  Virology       Date:  1985-09       Impact factor: 3.616

2.  Transformation and replication in mouse cells of a bovine papillomavirus--pML2 plasmid vector that can be rescued in bacteria.

Authors:  N Sarver; J C Byrne; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

3.  Virus-specific transcription in bovine papillomavirus-transformed mouse cells.

Authors:  C A Heilman; L Engel; D R Lowy; P M Howley
Journal:  Virology       Date:  1982-05       Impact factor: 3.616

4.  Biology and biochemistry of papillomaviruses.

Authors:  H Pfister
Journal:  Rev Physiol Biochem Pharmacol       Date:  1984       Impact factor: 5.545

5.  Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed.

Authors:  P Gunning; P Ponte; H Okayama; J Engel; H Blau; L Kedes
Journal:  Mol Cell Biol       Date:  1983-05       Impact factor: 4.272

6.  Genital warts and cervical cancer. III. Subclinical papillomaviral infection and cervical neoplasia are linked by a spectrum of continuous morphologic and biologic change.

Authors:  R Reid; C P Crum; B R Herschman; Y S Fu; L Braun; K V Shah; S J Agronow; C R Stanhope
Journal:  Cancer       Date:  1984-02-15       Impact factor: 6.860

7.  Molecular cloning and physical mapping of murine cytomegalovirus DNA.

Authors:  A Ebeling; G M Keil; E Knust; U H Koszinowski
Journal:  J Virol       Date:  1983-09       Impact factor: 5.103

8.  Bovine papillomavirus type 1 genome in hamster sarcoma cells in vivo and in vitro: variation in the level of transcription.

Authors:  G Jaureguiberry; M Favre; G Orth
Journal:  J Gen Virol       Date:  1983-05       Impact factor: 3.891

9.  A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions.

Authors:  M Dürst; L Gissmann; H Ikenberg; H zur Hausen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

10.  Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences.

Authors:  M F Law; D R Lowy; I Dvoretzky; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

View more
  15 in total

1.  Messenger RNAs from the E1 region of bovine papillomavirus type 1 detected in virus-infected bovine cells.

Authors:  S Burnett; J Moreno-Lopez; U Pettersson
Journal:  Nucleic Acids Res       Date:  1987-11-11       Impact factor: 16.971

2.  Identification of bovine papillomavirus E1 mutants with increased transforming and transcriptional activity.

Authors:  J T Schiller; E Kleiner; E J Androphy; D R Lowy; H Pfister
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

3.  Bovine papillomavirus transcriptional regulation: localization of the E2-responsive elements of the long control region.

Authors:  B A Spalholz; P F Lambert; C L Yee; P M Howley
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

4.  Anomalous transforming behavior of a bovine papillomavirus type 1 mutant with an upstream promoter mutation.

Authors:  A C Stewart; S Burnett
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

5.  An element in the bovine papillomavirus late 3' untranslated region reduces polyadenylated cytoplasmic RNA levels.

Authors:  P A Furth; C C Baker
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

6.  Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: structural and functional analysis of new viral cDNAs.

Authors:  J Choe; P Vaillancourt; A Stenlund; M Botchan
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

7.  Involvement of human papillomavirus type 8 genes E6 and E7 in transformation and replication.

Authors:  T Iftner; S Bierfelder; Z Csapo; H Pfister
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

8.  The E2 transactivator of bovine papillomavirus type 1 is expressed from multiple promoters.

Authors:  P Vaillancourt; T Nottoli; J Choe; M R Botchan
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

9.  Epidermal growth factor (EGF) elicits down-regulation of human papillomavirus type 16 (HPV-16) E6/E7 mRNA at the transcriptional level in an EGF-stimulated human keratinocyte cell line: functional role of EGF-responsive silencer in the HPV-16 long control region.

Authors:  S Yasumoto; A Taniguchi; K Sohma
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

10.  Promoters and processing sites within the transforming region of bovine papillomavirus type 1.

Authors:  H Ahola; A Stenlund; J Moreno-López; U Pettersson
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.